| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetes | |||||
| Retinopathy | |||||
| Vascular Pathology | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Retinal Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Eye Diseases | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Acetylcholine | |||||
| Nitroglycerin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Cardiovascular Agents | |||||
| Cholinergic Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| Yale University | |||||
|
